Time to try this warfarin alternative?
Abstract
Consider dabigatran, an oral anticoagulant that does not require monitoring, for the prevention of stroke and thromboembolism in patients with atrial fibrillation. Stength of recommendation: B: Based on a single well-done randomized controlled trial (RCT).
Rights
OpenAccess.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.